Meiji Yasuda Life Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$590K	Hold	10,451	–	–	0.02%	175
2025 Q4	$621K	Hold	10,451	–	–	0.02%	172
2025 Q3	$566K	Hold	10,451	–	–	0.02%	177
2025 Q2	$574K	Hold	10,451	–	–	0.02%	178
2025 Q1	$739K	Sell	10,451 -491	-4%	-$33K	0.01%	169
2024 Q4	$719K	Hold	10,942	–	–	0.01%	173
2024 Q3	$769K	Hold	10,942	–	–	0.01%	166
2024 Q2	$901K	Buy	10,942 +4,000	+58%	+$333K	0.02%	168
2024 Q1	$606K	Sell	6,942 -1,934	-22%	-$173K	0.01%	204
2023 Q4	$856K	Sell	8,876 -980	-10%	-$86.7K	0.02%	180
2023 Q3	$872K	Sell	9,856 -339	-3%	-$30.2K	0.02%	166
2023 Q2	$884K	Buy	10,195 +670	+7%	+$63.1K	0.02%	173
2023 Q1	$926K	Buy	9,525 +1,278	+15%	+$132K	0.02%	166
2022 Q4	$853K	Buy	8,247 +450	+6%	+$42.2K	0.02%	165
2022 Q3	$661K	Buy	7,797 +3,857	+98%	+$343K	0.01%	190
2022 Q2	$327K	Buy	+3,940	New	+$314K	0.01%	237

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meiji Yasuda Life Insurance's BMRN Position: Q1 2026 in Review

Meiji Yasuda Life Insurance held its BioMarin Pharmaceuticals (BMRN) position steady in Q1 2026 at 10,451 shares worth $590K. The position accounts for 0.02% of the portfolio, ranked #175.

Meiji Yasuda Life Insurance first reported a position in BMRN in Q2 2022 and has held it in 16 quarters since. The position peaked at $926K in Q1 2023. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Meiji Yasuda Life Insurance held 10,451 shares of BioMarin Pharmaceuticals worth $590K as of Q1 2026.
Meiji Yasuda Life Insurance left its BioMarin Pharmaceuticals share count unchanged in Q1 2026.
BioMarin Pharmaceuticals made up 0.02% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #175 holding.
Meiji Yasuda Life Insurance first reported a position in BioMarin Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
Meiji Yasuda Life Insurance's BioMarin Pharmaceuticals position peaked at $926K in Q1 2023.
555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.